JPH08291039A - Skin-lightening cosmetic - Google Patents

Skin-lightening cosmetic

Info

Publication number
JPH08291039A
JPH08291039A JP11776095A JP11776095A JPH08291039A JP H08291039 A JPH08291039 A JP H08291039A JP 11776095 A JP11776095 A JP 11776095A JP 11776095 A JP11776095 A JP 11776095A JP H08291039 A JPH08291039 A JP H08291039A
Authority
JP
Japan
Prior art keywords
skin
carnitine
ascorbic acid
cosmetic
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP11776095A
Other languages
Japanese (ja)
Other versions
JP3229517B2 (en
Inventor
Kyotaro Hasunuma
喬太郎 蓮沼
Shusuke Hanaoka
秀典 花岡
Ichiro Kobayashi
一郎 小林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanebo Ltd
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Priority to JP11776095A priority Critical patent/JP3229517B2/en
Publication of JPH08291039A publication Critical patent/JPH08291039A/en
Application granted granted Critical
Publication of JP3229517B2 publication Critical patent/JP3229517B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

PURPOSE: To obtain a skin-lightening cosmetic which can rapidly bleaching the dark skin by using carnitine and/or carnitine chloride and an ascorbic acid derivative. CONSTITUTION: This cosmetic contains 0.01-30wt.% of carnitine and/or carnitine chloride and 0.01-3wt.% of an ascorbic acid derivative. In addition, colorants, perfumes, a preservative, surfactants, pigments, an antioxidant, a moisturizer, an ultraviolet absorbent are properly formulated to prepare a cosmetic in the form of cream, emulsion, cosmetic lotion, pack, essence or powder. Carnitine and carnitine chloride promote the skin functions to improve the skin fatigue or loosening and prevent skin aging and wrinkles, give the skin a moistened feeling and gloss and accelerate the metabolism of the hair roots. The combination with an ascorbic acid derivative develops a synergistic effect on the actions cited above, and further, exhibits an inhibitory effect on melanin formation and a lightening effect on skin color.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は色黒の皮膚を速やかに淡
色化する効果を有する美白化粧料に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a whitening cosmetic having an effect of rapidly lightening dark skin.

【0002】[0002]

【従来技術及び発明が解決しようとする課題】従来よ
り、肌のしみやそばかす等の予防や治療を目的とする美
白化粧料には、アスコルビン酸およびその誘導体、ハイ
ドロキノン誘導体、コウジ酸等のピロン類、プラセンタ
ーエキス等の胎盤抽出物が配合されている。
BACKGROUND OF THE INVENTION Conventionally, whitening cosmetics for the purpose of preventing or treating spots and freckles on the skin include ascorbic acid and its derivatives, hydroquinone derivatives, pyrones such as kojic acid. , Placenta extract such as placenta extract are mixed.

【0003】これらの物質は、メラニン生成の抑制、生
成したメラニンの淡色漂白作用等の効果を有し、美白効
果を有する物質として広く知られている。しかし、これ
らの物質は、例えばアスコルビン酸およびその誘導体
は、保存安定性が不十分であったり、紫外線による炎症
防止効果が十分に認められないことが多い。また、ハイ
ドロキノン誘導体は安全性が十分ではないなど問題があ
る。このようにメラニンの生成抑制効果、メラニンの淡
色漂白作用、炎症防止効果、安全性等において総合的に
優れる美白化粧料を得ることは困難である。
These substances are widely known as substances having a whitening effect because they have the effects of suppressing the production of melanin, light-color bleaching action of the produced melanin and the like. However, these substances, for example, ascorbic acid and its derivatives, often have insufficient storage stability or do not have sufficient anti-inflammatory effect due to ultraviolet rays. Further, the hydroquinone derivative has problems such as insufficient safety. As described above, it is difficult to obtain a whitening cosmetic composition that is comprehensively excellent in the effect of suppressing the production of melanin, the light-color bleaching action of melanin, the effect of preventing inflammation, and the safety.

【0004】即ち、本発明の目的は、メラニンの生成抑
制効果、メラニンの淡色漂白作用、に優れている美白化
粧料を提供することにある。
That is, an object of the present invention is to provide a whitening cosmetic composition which is excellent in the effect of suppressing the production of melanin and the light-color bleaching action of melanin.

【0005】[0005]

【課題を解決するための手段】本発明者らは、上記目的
を達成するために鋭意検討した結果、化粧料中にカルニ
チン及び/又は塩化カルニチンと、アスコルビン酸誘導
体とを組み合わせて配合した場合、メラニンの生成抑制
効果、メラニンの淡色漂白作用、に優れている美白化粧
料が得られることを見出し本発明を完成した。
Means for Solving the Problems As a result of intensive studies to achieve the above object, the present inventors have found that when carnitine and / or carnitine chloride and an ascorbic acid derivative are combined in a cosmetic composition, The present invention has been completed by finding that a whitening cosmetic excellent in the effect of suppressing the production of melanin and the light-color bleaching action of melanin can be obtained.

【0006】本発明に用いられるカルニチン(Carn
itine)とは、γ−アミノ−β−ヒドロキシブチロ
ベタイン(3−Carboxy−2−Hydroxy−
N,N−N,trimethyl−1−propami
nium hydroxide、C7 15NO3 )で、
骨格筋の塩基性成分として広く存在し、通常はブタ、子
牛、ウマの肉から抽出され、アシルカルニチンの形でミ
トコンドリアへの脂肪酸輸送に関与し、そこでの脂肪酸
酸化を促進する働きのほか、脂肪酸合成促進の作用をす
ることが知られている。又、塩化カルニチンとはカルニ
チンの塩であるγ−アミノ−β−ヒドロキシブチロベタ
インハイドロクロライド(C7 16ClNO3 )で、人
体消化液中の消化酵素や酸の濃度を増加せしめると共に
胃液の分泌を促進するため、内服や注射液にて胃液分泌
障害、胃液減少症、食欲不振等に用いられている。カル
ニチン、塩化カルニチンは水溶性物質で、化学構造的に
光学異性体であり、D型、L型、その混合体であるDL
型があり、そののいずれも本発明に使用できる。
Carnitine (Carn) used in the present invention
Itine) means γ-amino-β-hydroxybutyrobetaine (3-Carboxy-2-Hydroxy-
N, N-N, trimethyl-1-propami
Numerous hydroxide, C 7 H 15 NO 3 ),
Widely present as a basic component of skeletal muscle, usually extracted from meat of pigs, calves, and horses, involved in fatty acid transport to mitochondria in the form of acylcarnitine, and promoting fatty acid oxidation there. It is known to act to promote fatty acid synthesis. In addition, carnitine chloride is a salt of carnitine, γ-amino-β-hydroxybutyrobetaine hydrochloride (C 7 H 16 ClNO 3 ), which increases the concentration of digestive enzymes and acids in human digestive juices and increases the concentration of gastric juice. In order to promote secretion, it is used by oral administration and injection for gastric juice secretion disorder, hypogastric juice, anorexia, etc. Carnitine and carnitine chloride are water-soluble substances, which are optical isomers in terms of chemical structure, D-type, L-type, and DL which is a mixture thereof.
There are molds, any of which can be used in the present invention.

【0007】本発明者らは、特開昭51−148042
号で、カルニチン、塩化カルニチンが皮膚機能を亢進し
皮膚の疲労やたるみを治癒せしめ、皮膚の老化や小皺を
防止し、しっとりと色艶のある皮膚にする美肌作用と共
に、毛根の代謝を促進して頭部毛根の発育を促進するこ
とを見出して提案した。しかし、上記カルニチン、塩化
カルニチン単独では、メラニンの生成抑制する効果は殆
ど認められなかったが、今回、本発明者らは、カルニチ
ン、塩化カルニチンをアスコルビン酸誘導体と組み合わ
せて配合した場合、顕著に相乗効果を発揮して、メラニ
ンの生成抑制効果を向上させ、皮膚を淡色化する効果を
発現することを新たに認められた。
The inventors of the present invention have disclosed in Japanese Patent Laid-Open No. 51-148042.
Carnitine and carnitine chloride enhance skin function, cure skin fatigue and sagging, prevent skin aging and fine wrinkles, and make skin moist and shiny, while promoting hair root metabolism. We found that it promoted the development of head hair roots. However, the above carnitine and carnitine chloride alone showed almost no effect of suppressing the production of melanin, but this time, when the present inventors combined carnitine and carnitine chloride in combination with an ascorbic acid derivative, they were remarkably synergistic. It has been newly confirmed that it exerts its effect, improves the effect of suppressing the production of melanin, and exerts the effect of lightening the skin.

【0008】以下、本発明の構成について詳述する。本
発明で用いられるアスコルビン酸誘導体は、公知の美白
剤であり、アスコルビン酸、アスコルビン酸リン酸エス
テル、アスコルビン酸硫酸エステル、アスコルビン酸高
級脂肪酸エステル等及びそれらの塩等であり、それらの
塩としてはナトリウム塩、カリウム塩、マグネシウム
塩、カルシウム塩、バリウム塩、アンモニウム塩、モノ
エタノールアミン塩、ジエタノールアミン塩、トリエタ
ノールアミン塩、モノイソプロパノールアミン塩、ジイ
ソプロパノールアミン塩、トリイソプロパノールアミン
塩等が挙げられるが、これらに限定されるものではな
い。
The structure of the present invention will be described in detail below. The ascorbic acid derivative used in the present invention is a known whitening agent, and ascorbic acid, ascorbic acid phosphoric acid ester, ascorbic acid sulfuric acid ester, ascorbic acid higher fatty acid ester, and salts thereof, and the like, and as salts thereof, Sodium salt, potassium salt, magnesium salt, calcium salt, barium salt, ammonium salt, monoethanolamine salt, diethanolamine salt, triethanolamine salt, monoisopropanolamine salt, diisopropanolamine salt, triisopropanolamine salt and the like. However, the present invention is not limited to these.

【0009】前記アスコルビン酸リン酸エステルとして
は、例えばアスコルビン酸−2−リン酸エステル、アス
コルビン酸−3−リン酸エステルが、またアスコルビン
酸硫酸エステルとしては、例えばアスコルビン酸−2−
硫酸エステル、アスコルビン酸−3−硫酸エステルであ
り、これらは公知の物質であって特公昭44−3123
7号公報、特公昭54−21415号公報に記載されて
いる。更にまたアスコルビン酸高級脂肪酸エステルとし
ては、例えばアスコルビン酸−2−パルミチン酸モノエ
ステル、アスコルビン酸−2,6−パルミチン酸ジエス
テル等が挙げられる。
Examples of the ascorbic acid phosphoric acid ester include ascorbic acid-2-phosphoric acid ester and ascorbic acid-3-phosphoric acid ester, and examples of the ascorbic acid sulfuric acid ester include ascorbic acid-2-phosphoric acid ester.
Sulfuric acid ester and ascorbic acid-3-sulfuric acid ester, which are known substances and are disclosed in Japanese Examined Patent Publication No.
No. 7 and Japanese Patent Publication No. 54-21415. Furthermore, examples of higher ascorbic acid fatty acid ester include ascorbic acid-2-palmitic acid monoester and ascorbic acid-2,6-palmitic acid diester.

【0010】カルニチン及び/又は塩化カルニチンの配
合量は、美白化粧料の処方成分全量を基準として、0.
01〜3.0重量%が好ましい。又、アスコルビン酸誘
導体の美白化粧料中の含有量は、化粧料の処方成分全量
を基準として、0.01〜30重量%が好ましく、更に
好ましくは0.1〜10重量%の範囲内である。
The content of carnitine and / or carnitine chloride is 0.
01 to 3.0% by weight is preferable. The content of the ascorbic acid derivative in the whitening cosmetic composition is preferably 0.01 to 30% by weight, more preferably 0.1 to 10% by weight, based on the total amount of the prescription components of the cosmetic composition. .

【0011】本発明の美白化粧料には、上記添加剤の他
に、色素、香料、防腐剤、界面活性剤、顔料、抗酸化
剤、保湿剤、紫外線吸収剤などを、本発明の目的を達成
する範囲内で適宜配合することができる。
In addition to the above-mentioned additives, the whitening cosmetic composition of the present invention contains, in addition to the above-mentioned additives, pigments, fragrances, preservatives, surfactants, pigments, antioxidants, humectants, ultraviolet absorbers and the like. It can be appropriately blended within the range to be achieved.

【0012】本発明の美白化粧料の剤型としては通常の
ものが適用され、たとえばクリーム、乳液、化粧水、パ
ック、エッセンス、粉体化粧料等が挙げられる。例えば
乳液の場合、油相及び水相をそれぞれ加熱溶解したもの
を乳化分散して冷却する通常の方法により製造すること
ができる。
As the dosage form of the whitening cosmetic composition of the present invention, usual ones are applied, and examples thereof include creams, emulsions, lotions, packs, essences, powder cosmetics and the like. For example, in the case of an emulsion, it can be produced by an ordinary method in which an oil phase and an aqueous phase are heated and dissolved, and then emulsified and dispersed and cooled.

【0013】[0013]

【実施例】以下、実施例及び比較例に基づいて本発明を
詳述する。尚、実施例に示す%とは重量%である。実施
例に記載の皮膚色明度回復試験法、官能評価試験は下記
のとおりである。
EXAMPLES The present invention will be described in detail below based on examples and comparative examples. In addition,% shown in the examples is% by weight. The skin color lightness recovery test method and sensory evaluation test described in Examples are as follows.

【0014】(1)皮膚色明度回復試験法 被験者20名の背部皮膚にUV−B領域の紫外線を最小
紅斑量の2倍照射し、試料塗布部位と非塗布部位を設定
して各々の皮膚の基準明度(V0 値,V0 ´値)を測定
した。引き続いて塗布部位には試料を1日2回ずつ15
週間連続塗布した後、3,6,9,12,15週間後の
塗布部位及び非塗布部位の皮膚の明度(Vn 値,Vn ´
値)を測定し、下記の判定基準にしたがって皮膚色の回
復を評価した。尚、皮膚の明度(マンセル表色系V値)
は高速分光色彩計で測定して得られたX,Y,Z値より
算出した。また評価は被験者20名ついて、3週間後及
び6週間後の評価点の平均値で示した。
(1) Skin color lightness recovery test method The back skin of 20 subjects was irradiated with ultraviolet rays in the UV-B region at twice the minimum erythema dose, and a sample application site and a non-application site were set to determine the skin of each skin. The standard brightness (V0 value, V0 'value) was measured. Subsequently, the sample is applied to the application site twice a day 15 times.
Lightness (Vn value, Vn 'of the skin at the application site and non-application site after 3,6,9,12,15 weeks after continuous application for a week
Value) was measured and the recovery of skin color was evaluated according to the following criteria. The brightness of the skin (V value of Munsell color system)
Was calculated from X, Y, and Z values obtained by measurement with a high-speed spectrocolorimeter. The evaluation was shown by the average value of the evaluation points of 20 subjects after 3 weeks and 6 weeks.

【0015】 [0015]

【0016】(2)官能評価試験 色素沈着に悩む被験者25名が試料を3週間連用し美白
効果を評価した。結果は「美白効果があった」と回答し
た被験者の人数で示した。
(2) Sensory evaluation test 25 subjects who suffered from pigmentation evaluated the whitening effect by continuously using the sample for 3 weeks. The results are shown by the number of subjects who answered that there was a whitening effect.

【0017】実施例1〜3,比較例1〜4 カルニチン、塩化カルニチン、アスコルビン酸−2−リ
ン酸エステル塩、アスコルビン酸−2−硫酸エステル塩
を表1の組成において配合し、下記の調製方法に基づい
てスキンクリームを調製した。
Examples 1 to 3 and Comparative Examples 1 to 4 Carnitine, carnitine chloride, ascorbic acid-2-phosphate ester salt, and ascorbic acid-2-sulfate ester salt were blended in the composition shown in Table 1, and the following preparation method was used. A skin cream was prepared based on

【0018】調製方法 (A)を70℃、Bを50℃にて均一に溶解し、(A)
を攪拌しながら(B)を(A)に注入して乳化分散した
後、攪拌しながら温度30℃まで冷却して調製する。
Preparation method (A) is uniformly dissolved at 70 ° C. and B at 50 ° C. to prepare (A)
(B) is poured into (A) with stirring to emulsify and disperse, and then cooled to 30 ° C. with stirring to prepare.

【0019】[0019]

【表1】 [Table 1]

【0020】[0020]

【表2】 [Table 2]

【0021】これらのスキンクリームを試料として前記
の試験を実施し、得られた結果を表3に示す。
The above test was carried out using these skin creams as samples, and the results obtained are shown in Table 3.

【0022】[0022]

【表3】 [Table 3]

【0023】これらの結果から分かるように、本発明の
実施例1〜3のスキンクリームは十分な美白効果が認め
られた。一方、比較例1〜4のスキンクリームは、十分
な効果が認められず、本発明の実施例に比べて劣ってい
た。
As can be seen from these results, the skin creams of Examples 1 to 3 of the present invention were found to have a sufficient whitening effect. On the other hand, the skin creams of Comparative Examples 1 to 4 did not show a sufficient effect and were inferior to the examples of the present invention.

【0024】[0024]

【発明の効果】以上記載のごとく、本発明が色黒の皮膚
を速やかに淡色化する効果を有する美白化粧料を提供す
ることは明らかである。
As described above, it is apparent that the present invention provides a whitening cosmetic having an effect of rapidly lightening dark skin.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 カルニチン及び/又は塩化カルニチン
と、アスコルビン酸誘導体とを組み合わせて配合するこ
とを特徴とする美白化粧料。
1. A whitening cosmetic composition comprising carnitine and / or carnitine chloride in combination with an ascorbic acid derivative.
JP11776095A 1995-04-18 1995-04-18 Whitening cosmetics Expired - Fee Related JP3229517B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11776095A JP3229517B2 (en) 1995-04-18 1995-04-18 Whitening cosmetics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11776095A JP3229517B2 (en) 1995-04-18 1995-04-18 Whitening cosmetics

Publications (2)

Publication Number Publication Date
JPH08291039A true JPH08291039A (en) 1996-11-05
JP3229517B2 JP3229517B2 (en) 2001-11-19

Family

ID=14719652

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11776095A Expired - Fee Related JP3229517B2 (en) 1995-04-18 1995-04-18 Whitening cosmetics

Country Status (1)

Country Link
JP (1) JP3229517B2 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001047479A3 (en) * 1999-12-28 2002-02-21 Colgate Palmolive Co Skin moisturizing composition
WO2002102338A1 (en) * 2001-06-19 2002-12-27 Beiersdorf Ag Carnitine and acyl-carnitines used in the treatment and prophylaxis of pigmentation disorders
KR20030066912A (en) * 2002-02-06 2003-08-14 한불화장품주식회사 A cosmetic composition
JP2004339141A (en) * 2003-05-15 2004-12-02 Kanebo Ltd Skin cosmetic
JP2004339140A (en) * 2003-05-15 2004-12-02 Kanebo Ltd Skin cosmetic
JP2006522807A (en) * 2003-03-28 2006-10-05 ロンザ インコーポレイテッド Topical L-carnitine composition
KR100678865B1 (en) * 2005-08-30 2007-02-05 주식회사 코리아나화장품 Cosmetic composition for skin whitening comprising ramulus mori extract and carnitine as active ingredient
KR100678864B1 (en) * 2005-08-30 2007-02-05 주식회사 코리아나화장품 Cosmetic composition for skin whitening comprising cnidium officinale extract and carnitine as active ingredient

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001047479A3 (en) * 1999-12-28 2002-02-21 Colgate Palmolive Co Skin moisturizing composition
WO2002102338A1 (en) * 2001-06-19 2002-12-27 Beiersdorf Ag Carnitine and acyl-carnitines used in the treatment and prophylaxis of pigmentation disorders
KR20030066912A (en) * 2002-02-06 2003-08-14 한불화장품주식회사 A cosmetic composition
JP2006522807A (en) * 2003-03-28 2006-10-05 ロンザ インコーポレイテッド Topical L-carnitine composition
JP2004339141A (en) * 2003-05-15 2004-12-02 Kanebo Ltd Skin cosmetic
JP2004339140A (en) * 2003-05-15 2004-12-02 Kanebo Ltd Skin cosmetic
KR100678865B1 (en) * 2005-08-30 2007-02-05 주식회사 코리아나화장품 Cosmetic composition for skin whitening comprising ramulus mori extract and carnitine as active ingredient
KR100678864B1 (en) * 2005-08-30 2007-02-05 주식회사 코리아나화장품 Cosmetic composition for skin whitening comprising cnidium officinale extract and carnitine as active ingredient

Also Published As

Publication number Publication date
JP3229517B2 (en) 2001-11-19

Similar Documents

Publication Publication Date Title
US7754249B2 (en) Haircare compositions and methods
JPH06506668A (en) Use of growth factors in slimming compositions
JPH08333260A (en) Skin preparation for external use
JP2000229834A (en) Cosmetic
JPH04124122A (en) Blackening agent of preventing gray hair
JP2002173449A (en) Hair-growing agent
JP3229517B2 (en) Whitening cosmetics
KR20230074749A (en) Hair, scalp and skin treatment composition
JPS63115807A (en) Cosmetic
KR20100024322A (en) Shampoo composition for alopecia prevention and hair growth
JPH11269043A (en) Cosmetic for scalp and hair
US20030215409A1 (en) Process for the treatment of human keratinous fibers
JP2001131031A (en) Composition for scalp and hair
JP3853773B2 (en) Hair nourishing
JPH0363207A (en) Skin cosmetic
JPS6233111A (en) Hair tonic composition
JPH08113516A (en) Composition for scalp
JP2000026269A (en) Cosmetic
JPH06256140A (en) Beautifying cosmetic
JP2811479B2 (en) Hair restoration
KR20090070089A (en) Composition for prevention of hair loss and stimulation of hair growh
JP2003277251A (en) New beautifying and whitening cosmetic
JP3229594B2 (en) Whitening cosmetics
JPH11302128A (en) Cosmetic for scalp and hair
JP2000297011A (en) Bleaching cosmetic

Legal Events

Date Code Title Description
S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090907

Year of fee payment: 8

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100907

Year of fee payment: 9

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110907

Year of fee payment: 10

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120907

Year of fee payment: 11

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130907

Year of fee payment: 12

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees